1-[(2,4-Dichlorophenyl)methyl]-3'-phenyl-1,2-dihydrospiro[indole-3,2'-[1,3]thiazolidine]-2,4'-dione

Catalog No. :
ACJDOM607
CAS No. :
338418-91-0
Molecular Formula :
C23H16Cl2N2O2S
Molecular Weight :
455.37

IUPAC Name:1-(2,4-dichlorobenzyl)-3'-phenylspiro[indoline-3,2'-thiazolidine]-2,4'-dione

1-[(2,4-Dichlorophenyl)methyl]-3'-phenyl-1,2-dihydrospiro[indole-3,2'-[1,3]thiazolidine]-2,4'-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$295.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(2,4-Dichlorophenyl)methyl]-3'-phenyl-1,2-dihydrospiro[indole-3,2'-[1,3]thiazolidine]-2,4'-dione
IUPAC Name1-(2,4-dichlorobenzyl)-3'-phenylspiro[indoline-3,2'-thiazolidine]-2,4'-dione
MDL No.MFCD00140920
Molecular FormulaC23H16Cl2N2O2S
Molecular Weight455.37
SMILESO=C1N(CC2=CC=C(Cl)C=C2Cl)C3=C(C=CC=C3)C14SCC(N4C5=CC=CC=C5)=O
InChI KeyWFNKGOWBCFRIHT-UHFFFAOYSA-N
Synonym1-(2,4-DICHLOROBENZYL)-3'-PHENYLSPIRO(2,3-DIHYDRO-1H-INDOLE-3,2'-THIAZOLIDINE)-2,4'-DIONE;1-[(2,4-dichlorophenyl)methyl]-3'-phenyl-1,2-dihydrospiro[indole-3,2'-[1,3]thiazolidine]-2,4'-dione;Spiro[3H-indole-3,2'-thiazolidine]-2,4'(1H)-dione, 1-[(2,4-dichlorophenyl)methyl]-3'-phenyl-
CAS No.338418-91-0

Synthetic Route by SureRoute

1. ACJDOM607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWGM620 route compound structure diagram
    ACOWGM62020443-99-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJDOM607 route product structure diagram
    ACJDOM607338418-91-0
Inquiry

2. ACJDOM607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJDOM607 route product structure diagram
    ACJDOM607338418-91-0
Inquiry

Comments (0)